pelvic inflammatory disease. Female pelvic inflammatory disease, unspecified
Conditions
Interventions
Intervention 1: Control group: patients treated with doxycycline. Intervention 2: Intervention group: patients treated with azithromycin.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 35 Years
Inclusion criteria
Inclusion criteria: Sub fertile women 15-35 year old Do not take any antibiotics during the week before the procedure
Exclusion criteria
Exclusion criteria: History of severe drug allergy to doxycycline and azithromycin (anaphylactic shock, cutaneous rash, and complications leading to hospitalization) Active pelvic inflammation Previously known history of pelvic infection Known case of endometriosis History of ectopic pregnancy History of fallopian tube surgery Pregnancy Severe uterine bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic inflammatory disease is defined as a clinical diagnosis including fever and chills. Vaginal discharge. Abdominal pain. Timepoint: Evaluation of patients' symptoms for pelvic inflammatory infection 2 weeks after hysterosalpingography and in case of patients with symptoms of pelvic inflammatory infection , Follow up patients for the next 2 weeks after symptoms resolve. Method of measurement: Visit the doctor by phone and check the patient's symptoms and if any of the symptoms are fever and chills, vaginal discharge and hypogastric pain, see a gynecologist and after examining the patient and prescribing appropriate treatment, follow up patients for 2 weeks until complete relief of symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects, nausea and vomiting. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient.;Drug side effects, diarrhea. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient.;Drug side effects, abdominal pain. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rezaei
Arak University of Medical Sciences
Outcome results
None listed